CIS
CIS

Clinical Immunology Society (CIS)

2015 Annual Meeting: Immune Deficiency and Dysregulation North American Conference

Continuing Medical Education

2015 Annual Meeting

Purpose
The purpose is to provide an intellectual forum for all clinicians and researchers from around the world to discuss diagnosis, pathogenesis, and management of the regulation and dysregulation of immunity.

Target Audience
The target audience is physicians and researchers working in various clinical immunology specialties including, but not limited to, allergy, autoimmunity, dermatology, gastroenterology, hematology, infectious disease, primary immunodeficiency, rheumatology, and transplantation.

Learning Objectives
At the completion of the activity participants should be able to:

  • Recognize the value of new research techniques;
  • Describe new research findings in immunology;
  • Explain the diagnosis and management of diseases and disorders across various subspecialties of medicine.

ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the Clinical Immunology Society (CIS). The CIS is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement
The Clinical Immunology Society designates this live activity for a maximum of 19 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Update in PID

Purpose
Derived from the need to understand how to treat primary immune deficiency diseases in the context of other diseases, the CIS developed the Update in Primary Immunodeficiency Diseases which is geared toward physicians and scientists who are involved in the evaluation and/or care of patients with primary immune deficiencies.

Target Audience
This program is designed for allergist-immunologists, primary care physicians, nursing professionals specializing in immunology and other medical professionals who treat primary immunodeficiency diseases.

Learning Objectives
At the completion of the activity participants should be able to:

  • Facilitate interactions among clinicians of diverse training to promote multicenter clinical trials and to coordinate participation in existing clinical trials.
  • Improve recognition of primary immune deficiencies.
  • Improve understanding of the diagnostic issues and the pathophysiology of primary immune deficiencies.
  • Improve understanding of the appropriate interventions for these diseases.

ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the Clinical Immunology Society (CIS). The CIS is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement
The Clinical Immunology Society designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.